ETC Awarded $2.6 Million Contract for its Environmental Testing and Simulation Unit

Written by Customer Service on November 12, 2021. Posted in Public Companies.

SOUTHAMPTON, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Environmental Testing and Simulation Unit has been awarded a $2.6 million project to provide climatic test equipment for a major, multinational truck and bus manufacturer. This environmental simulation equipment will provide the customer the capability to simulate specific operating conditions including wide ranges of temperature, humidity, and altitude. These systems will be used to test various vehicle types including diesel, natural gas, hybrid, and full electric in the areas of emissions, product development, and regulatory compliance. About ETC: ETC designs, manufactures, and sells software driven products and services used to recreate and monitor the physiological effects of motion on humans,...

Nocopi’s Q3 Cash Position Improved 12% from June 2021 to $2.1M Despite Drop in Product Revenue Related to Customer Supply Chain Challenges, Names New Independent Director

Written by Customer Service on November 12, 2021. Posted in Earnings Releases And Operating Results.

KING OF PRUSSIA, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its third quarter and nine months ended September 30, 2021 (Q3’21 & 9M’21). Nocopi’s SEC filings are available here. Q3’21 Results Q3’21 revenue declined 59% to $312,500 reflecting a decrease in product and other sales, principally due to specialty ink shipments for licensees in the entertainment and toy product market. In contrast, license and royalty revenue rose 45% to $222,500 reflecting growth in royalty income from toy and entertainment market customers. Revenue from security market customers was relatively unchanged at approximately...

Seneca Foods Reports Sales and Earnings for the Six Months Ended October 2, 2021

Written by Customer Service on November 12, 2021. Posted in Earnings Releases And Operating Results.

MARION, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) — Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the second quarter and six months ended October 2, 2021. Executive Summary (vs. year-ago, second quarter results): Net sales for the second quarter of fiscal 2022 totaled $372.3 million compared to $390.3 million in the second quarter of fiscal 2021. Gross margin as a percentage of net sales for the second quarter is 11.5% in 2022 as compared to 12.5% in 2021. Commenting on the results, Paul Palmby, President and Chief Executive Officer of Seneca Foods, stated, “We are pleased with the Company’s performance in the second quarter. A comparative perspective to the prior year remains a challenge given the 2020 COVID-19 pantry loading and the Truitt divestiture that happened in fiscal year 2021. However,...

Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

Written by Customer Service on November 12, 2021. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today announced results for the quarter ended September 30, 2021, and provided a business update. Highlights of the quarter and recent weeks include: Successful completion of the Company’s public listing (Nasdaq: JSPR) on September 27, 2021 following the business combination with Amplitude Healthcare Acquisition Corporation (AMHC) on September 24, 2021 Receipt of $100 million in gross proceeds through the closing of the concurrent companion PIPE transaction Enrollment of JSP191 Phase 1b study expansion cohorts in acute myeloid leukemia/myelodysplastic syndrome (AML/MDS) on track; top-line interim data expected Q1 2022 JSP191 Phase 1b severe combined immunodeficiency...

Rezolute Reports First Quarter Fiscal 2022 Financial Results and Highlights Recent Company Progress

Written by Customer Service on November 12, 2021. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced its financial results for the first quarter of fiscal 2022 ended September 30, 2021. “This has been a productive quarter of execution for Rezolute, with steady clinical advancement of our lead pipeline candidates, RZ358 and RZ402, in Phase 2b and Phase 1b development, respectively,” said Nevan Elam, Chief Executive Officer and Founder of Rezolute. “We look forward to announcing topline data for both programs in Q1 of 2022. Additionally, with a strengthened balance sheet following our recent offering, raising $55 million in gross proceeds, we have extended our cash runway and are well-positioned...

Usio to Participate in the Ladenburg Thalmann Virtual Technology Expo on November 18th

Written by Customer Service on November 12, 2021. Posted in Public Companies.

Presentation on Thursday, November 18, 2021, at 11:30AM ET SAN ANTONIO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), a leading FinTech integrated payment solutions provider, today announced it will participate in the Ladenburg Thalmann Virtual Technology Expo taking place November 18, 2021. Louis Hoch, Chief Executive Officer, Greg Carter, Senior Vice President, Payment Facilitation, and Houston Frost, Senior Vice President, Prepaid Services, will conduct one-on-one meetings with investors. For more information on the conference or to register, visit: https://ladenburg21.mysequire.com/. Investors can also request one-on-one meetings with Usio on the event website. The Company will present on Thursday, November 18, 2021, at 11:30 a.m. ET. The event will also be available on the Usio website at https://usio.com/investors/ About...

Millicom (Tigo) closes Guatemala transaction

Written by Customer Service on November 12, 2021. Posted in Mergers And Acquisitions.

Millicom (Tigo) closes Guatemala transaction Luxembourg, November 12, 2021 – Millicom announced today that it has closed the previously-announced agreement to acquire the remaining 45% equity interest in its joint venture businesses in Guatemala. For further information, please contact Press:Vivian Kobeh, Director Corporate Communications +1-786-628-5300press@millicom.com Yocasta Valdez, Group Manager Digital Media & Communications+1-305-929-5417press@millicom.com Investors:Michel Morin, VP Investor Relations+1-786-628-5270investors@millicom.com Sarah Inmon, Director Investor Relations+1-786-628-5303investors@millicom.com About Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of fixed and mobile services dedicated to emerging markets in Latin America...

IDEX Biometrics: Subscription Rights Exercise – 12 Nov 2021

Written by Customer Service on November 12, 2021. Posted in Public Companies.

The board of directors of IDEX Biometrics ASA has resolved to issue in total 1,103,442 ordinary shares at average price NOK 1.65 per share to employees who have exercised incentive subscription rights. The incentive subscription rights were issued under the company’s 2019 and 2020 incentive subscription rights plans, which plans were approved by the annual general meeting on 9 May 2019 and 12 May 2020 respectively. The employees have paid the subscription amount to the company. Following the issue, the company’s share capital will be NOK 151,558,268.10 divided into 1,010,388,454 shares each with a nominal value of NOK 0.15. Following the exercise, there are 71.281.124 incentive subscription rights outstanding. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186 About...

Sorrento Therapeutics Mexico to Partner with the World Boxing Council for the Screening of COVID-19 of all Convention Attendees with COVI-STIX at the 59th World Boxing Council Convention in Mexico City

Written by Customer Service on November 12, 2021. Posted in Public Companies.

SAN DIEGO and MEXICO CITY, Nov. 12, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and the World Boxing Council (“WBC”) announced today that Sorrento’s COVI-STIX COVID-19 Virus Rapid Antigen Detection Test (“COVI-STIX”) will be used for screening all attendees of the upcoming 59th World Boxing Council Annual Convention in Mexico City, Mexico (November 14th through November 18th). The pandemic brought the world to a standstill and while most sports froze, boxing remained active through efforts by promoters, boxing commissions and the WBC. Boxing leads the world of sports in administrative and medical protocols to allow boxing matches to be held in bubbles without fans present. Testing is and should remain a major factor for the successful organization of any public event, including boxing events with...

IBEX Limited to Announce First Quarter Fiscal Year 2022 Financial Results on November 22, 2021

Written by Customer Service on November 12, 2021. Posted in Public Companies.

WASHINGTON, Nov. 12, 2021 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it will report first quarter fiscal year 2022 financial results after the market close on Monday, November 22, 2021. Management will host a conference call and webcast to discuss the Company’s financial results, recent developments and business outlook at 4:30 p.m. ET. What: ibex Limited Announces First Quarter Fiscal Year 2022 Financial Results When: Monday, November 22, 2021 Time: 4:30 p.m. ET Live Call: US/Canada Toll-Free: (833) 614-1408International: (914) 987-7129Conference ID: 3885337 Replay: US/Canada Toll-Free: (855) 859-2056International: (404) 537-3406Conference ID: 3885337(Available approximately...

Day: November 12, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice